MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
MS - RESEARCH AND NEWS
»
Clinical focus in MS: novel approaches to progressive disease
»
Message #1906
« previous
next »
Print
Pages: [
1
]
Author
Topic: Clinical focus in MS: novel approaches to progressive disease (Read 200 times)
0 Members and 1 Guest are viewing this topic.
agate
Administrator
Posts: 9842
MS diagnosed 1980
Location: Pacific Northwest
Re: Clinical focus in MS: novel approaches to progressive disease
«
on:
December 01, 2017, 02:38:31 pm »
According to Drugs.com, clemastine fumarate has the brand names Tavist Allergy, Tavist, Tavist-1, Allerhist-1, Dailyhist-1, Contac 12 Hour Allergy, Dayhist Allergy.
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
MS - RESEARCH AND NEWS
»
Clinical focus in MS: novel approaches to progressive disease
»
Message #1906